This inventor holds 54 USPTO granted patents and 28 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Analyte Sensing Technology. Top assignee: Abbott Diabetes Care Inc.. Active years: 2009-2025.
Location History:
- Pleasanton, CA (US) (2009 - 2017)
- Long Beach, CA (US) (2016 - 2024)
Company Filing History:
Years Active: 2009-2025
Areas of Expertise:
Title: Innovations and Contributions of John Charles Mazza
Introduction
John Charles Mazza, residing in Long Beach, CA, has made significant strides in the medical technology field with a remarkable portfolio of 49 patents. His innovative work focuses primarily on advancements in analyte monitoring systems, particularly for diabetes care, showcasing his dedication to improving healthcare technologies.
Latest Patents
Among Mazza's latest innovations are two notable patents. The first is a "Method and system for providing calibration of an analyte sensor in an analyte monitoring system." This invention outlines a sophisticated approach to calibrating an analyte sensor by applying a control signal, detecting measurable responses, determining variances in these responses, and estimating sensor sensitivity accordingly.
The second patent is titled "Method and apparatus for providing data processing and control in a medical communication system." This invention describes techniques for processing data within a glucose monitoring system. It includes steps for obtaining and comparing sensitivities of the glucose sensor to identify whether calibration routines need to be performed, thereby optimizing glucose level calculations for more accurate monitoring.
Career Highlights
Mazza's impressive body of work has been primarily executed at Abbott Diabetes Care Inc., where he contributes his expertise in developing cutting-edge technologies for diabetes management. His inventions have streamlined glucose monitoring processes, making them more reliable and user-friendly, thus enhancing patient care.
Collaborations
Throughout his career, John Charles Mazza has worked closely with brilliant minds in the field such as Gary Alan Hayter and Andrew H. Naegeli. Their collaborative efforts have been instrumental in driving forward innovative solutions in medical technology, showcasing the importance of teamwork in the advancement of healthcare inventions.
Conclusion
John Charles Mazza epitomizes the spirit of innovation in the medical technology sector. His substantial contribution through numerous patents and collaborative work not only reflects his expertise but also signifies a commitment to improving healthcare solutions for better patient outcomes. As the field of diabetes care continues to evolve, Mazza’s contributions will undoubtedly play a crucial role in shaping its future.